| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.747 | 0.018 | 0.747 | Caspase 9 stimulant | |||
| 0.589 | 0.004 | 0.589 | Alpha-N-acetylglucosaminidase inhibitor | 0.162 0.049 CID_131320 | ||
| 0.548 | 0.014 | 0.548 | Calcium channel L-type activator | |||
| 0.55 | 0.025 | 0.55 | Cholesterol antagonist | 0.474 0.037 CID_131320 | ||
| 0.523 | 0.03 | 0.523 | Aldehyde oxidase inhibitor | |||
| 0.496 | 0.035 | 0.496 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.304 0.208 CID_131320 | ||
| 0.487 | 0.029 | 0.487 | 5 Hydroxytryptamine release stimulant | |||
| 0.465 | 0.036 | 0.465 | Vasodilator, peripheral | |||
| 0.468 | 0.042 | 0.549 | Histamine release inhibitor | 0.549 0.016 CID_131320 | CID_131320 | |
| 0.421 | 0.005 | 0.421 | Neurotrophic factor enhancer | |||
| 0.439 | 0.046 | 0.439 | GABA C receptor rho-3 antagonist | |||
| 0.466 | 0.085 | 0.466 | Apoptosis agonist | 0.309 0.166 CID_131320 | ||
| 0.396 | 0.021 | 0.396 | Peroxidase inhibitor | 0.178 0.066 CID_131320 | ||
| 0.398 | 0.028 | 0.398 | Interleukin 2 agonist | |||
| 0.37 | 0.004 | 0.37 | Porphobilinogen synthase inhibitor | 0.104 0.034 CID_131320 | ||
| 0.383 | 0.018 | 0.383 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.183 CID_131320 | ||
| 0.425 | 0.064 | 0.425 | 5 Hydroxytryptamine release inhibitor | |||
| 0.387 | 0.031 | 0.387 | DNA damaging | |||
| 0.421 | 0.08 | 0.421 | Cyclophilin D inhibitor | 0.293 0.169 CID_131320 | ||
| 0.362 | 0.028 | 0.362 | DNA synthesis inhibitor | 0.202 0.121 CID_131320 | ||
| 0.331 | 0.005 | 0.331 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.337 | 0.014 | 0.337 | Amylase inhibitor | |||
| 0.333 | 0.015 | 0.333 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.32 | 0.009 | 0.32 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 CID_131320 | ||
| 0.326 | 0.023 | 0.326 | Tyrosine 3 hydroxylase inhibitor | 0.189 0.157 CID_131320 | ||
| 0.334 | 0.034 | 0.334 | Interleukin agonist | |||
| 0.345 | 0.053 | 0.345 | Calcium channel activator | |||
| 0.299 | 0.008 | 0.299 | Carbonic anhydrase XV inhibitor | 0.139 0.035 CID_131320 | ||
| 0.288 | 0.005 | 0.415 | Triose-phosphate isomerase inhibitor | 0.415 0.003 CID_131320 | CID_131320 | |
| 0.291 | 0.012 | 0.291 | DNA intercalator | 0.095 0.08 CID_131320 | ||
| 0.299 | 0.032 | 0.331 | RNA-directed DNA polymerase inhibitor | 0.331 0.026 CID_131320 | CID_131320 | |
| 0.271 | 0.004 | 0.271 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.022 CID_131320 | ||
| 0.272 | 0.005 | 0.272 | Photosensitizer | 0.135 0.042 CID_131320 | ||
| 0.331 | 0.066 | 0.331 | Caspase 3 stimulant | |||
| 0.268 | 0.004 | 0.268 | MAP3K9 inhibitor | 0.119 0.116 CID_131320 | ||
| 0.278 | 0.018 | 0.278 | Nitric-oxide synthase stimulant | |||
| 0.27 | 0.015 | 0.27 | Aldehyde dehydrogenase inhibitor | |||
| 0.325 | 0.07 | 0.325 | Apoptosis antagonist | |||
| 0.257 | 0.004 | 0.257 | Glutamate release inhibitor | |||
| 0.261 | 0.008 | 0.261 | Histidine decarboxylase inhibitor | |||
| 0.264 | 0.018 | 0.264 | Succinate dehydrogenase inhibitor | 0.188 0.059 CID_131320 | ||
| 0.297 | 0.054 | 0.297 | Hypoglycemic | |||
| 0.256 | 0.013 | 0.256 | GABA C receptor agonist | |||
| 0.304 | 0.064 | 0.304 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.169 CID_131320 | ||
| 0.303 | 0.07 | 0.303 | Lipoxygenase inhibitor | 0.231 0.113 CID_131320 | ||
| 0.318 | 0.086 | 0.318 | Transcription factor NF kappa B inhibitor | |||
| 0.248 | 0.017 | 0.248 | Topoisomerase I inhibitor | |||
| 0.306 | 0.076 | 0.306 | 12-Lipoxygenase inhibitor | |||
| 0.243 | 0.014 | 0.243 | Ferrochelatase inhibitor | |||
| 0.236 | 0.015 | 0.236 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.304 | 0.084 | 0.304 | Vasodilator, coronary | |||
| 0.24 | 0.019 | 0.24 | Hexokinase inhibitor | |||
| 0.247 | 0.027 | 0.247 | Protein kinase stimulant | |||
| 0.279 | 0.059 | 0.565 | Superoxide dismutase inhibitor | 0.565 0.008 CID_131320 | CID_131320 | |
| 0.269 | 0.055 | 0.269 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.231 | 0.018 | 0.231 | Cystathionine beta-synthase inhibitor | |||
| 0.371 | 0.158 | 0.658 | Antiinflammatory | 0.658 0.039 CID_131320 | CID_131320 | |
| 0.236 | 0.029 | 0.236 | NOS3 expression enhancer | |||
| 0.216 | 0.009 | 0.216 | NADH dehydrogenase inhibitor | 0.116 0.031 CID_131320 | ||
| 0.232 | 0.026 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.186 0.09 CID_131320 | ||
| 0.21 | 0.009 | 0.21 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.058 CID_131320 | ||
| 0.262 | 0.066 | 0.262 | Gastrin inhibitor | |||
| 0.214 | 0.018 | 0.214 | Toll-Like receptor 2 antagonist | |||
| 0.203 | 0.009 | 0.203 | Sphingomyelinase inhibitor | 0.092 0.07 CID_131320 | ||
| 0.207 | 0.017 | 0.207 | Nav1.6 sodium channel blocker | |||
| 0.243 | 0.054 | 0.243 | Anesthetic general | |||
| 0.198 | 0.009 | 0.198 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.206 | 0.018 | 0.206 | CF transmembrane conductance regulator agonist | |||
| 0.313 | 0.126 | 0.476 | Antibacterial | 0.476 0.048 CID_131320 | CID_131320 | |
| 0.272 | 0.088 | 0.373 | Immunostimulant | 0.373 0.058 CID_131320 | CID_131320 | |
| 0.197 | 0.015 | 0.197 | Adenylate cyclase stimulant | 0.174 0.031 CID_131320 | ||
| 0.257 | 0.076 | 0.257 | Aryl hydrocarbon receptor agonist | |||
| 0.231 | 0.051 | 0.231 | Non-steroidal antiinflammatory agent | |||
| 0.195 | 0.016 | 0.195 | Adenylate kinase inhibitor | 0.126 0.038 CID_131320 | ||
| 0.229 | 0.05 | 0.229 | Hepatoprotectant | 0.156 0.103 CID_131320 | ||
| 0.197 | 0.019 | 0.197 | Bronchodilator | |||
| 0.277 | 0.105 | 0.459 | Antithrombotic | 0.459 0.036 CID_131320 | CID_131320 | |
| 0.184 | 0.014 | 0.184 | Alcohol dehydrogenase inhibitor | |||
| 0.257 | 0.088 | 0.257 | Spasmolytic | 0.227 0.102 CID_131320 | ||
| 0.175 | 0.01 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.136 0.09 CID_131320 | ||
| 0.178 | 0.014 | 0.178 | Phosphofructokinase-1 inhibitor | 0.081 0.041 CID_131320 | ||
| 0.204 | 0.041 | 0.308 | Phospholipase C inhibitor | 0.308 0.018 CID_131320 | CID_131320 | |
| 0.248 | 0.085 | 0.248 | Antioxidant | 0.172 0.14 CID_131320 | ||
| 0.196 | 0.034 | 0.196 | Topoisomerase II inhibitor | |||
| 0.174 | 0.016 | 0.174 | Creatine kinase inhibitor | 0.11 0.05 CID_131320 | ||
| 0.197 | 0.04 | 0.197 | ATPase inhibitor | |||
| 0.177 | 0.021 | 0.177 | Carbonic anhydrase III inhibitor | 0.123 0.042 CID_131320 | ||
| 0.25 | 0.096 | 0.25 | Insulysin inhibitor | |||
| 0.186 | 0.033 | 0.186 | DNA polymerase I inhibitor | |||
| 0.189 | 0.036 | 0.189 | GABA C receptor rho-2 antagonist | |||
| 0.193 | 0.04 | 0.193 | Arachidonic acid antagonist | 0.131 0.111 CID_131320 | ||
| 0.28 | 0.128 | 0.28 | Immunosuppressant | |||
| 0.213 | 0.061 | 0.213 | Insulin sensitizer | |||
| 0.189 | 0.039 | 0.189 | Nav1.2 sodium channel blocker | 0.153 0.055 CID_131320 | ||
| 0.16 | 0.01 | 0.16 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 CID_131320 | ||
| 0.164 | 0.017 | 0.164 | Prolactin inhibitor | |||
| 0.155 | 0.008 | 0.155 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.176 | 0.03 | 0.276 | Antibacterial (Helicobacter pylori) | 0.276 0.009 CID_131320 | CID_131320 | |
| 0.15 | 0.005 | 0.15 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.178 | 0.034 | 0.178 | Alkylator | 0.117 0.071 CID_131320 | ||
| 0.183 | 0.038 | 0.254 | Cell wall synthesis inhibitor | 0.254 0.015 CID_131320 | CID_131320 | |
| 0.154 | 0.01 | 0.154 | Alcohol oxidase inhibitor | |||
| 0.189 | 0.046 | 0.189 | Melanin inhibitor | |||
| 0.237 | 0.094 | 0.237 | Transcription factor STAT3 inhibitor | |||
| 0.188 | 0.046 | 0.188 | Interferon gamma antagonist | |||
| 0.172 | 0.032 | 0.172 | Cyclooxygenase 3 inhibitor | |||
| 0.159 | 0.019 | 0.159 | Carbonic anhydrase VI inhibitor | 0.098 0.041 CID_131320 | ||
| 0.171 | 0.031 | 0.171 | 5-Lipoxygenase inhibitor | |||
| 0.143 | 0.004 | 0.143 | Glucosylceramidase inhibitor | |||
| 0.164 | 0.025 | 0.164 | Mucolytic | |||
| 0.224 | 0.087 | 0.224 | Vasodilator | |||
| 0.161 | 0.025 | 0.161 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.162 | 0.025 | 0.162 | Protein kinase C gamma inhibitor | |||
| 0.146 | 0.01 | 0.146 | Biliverdin reductase inhibitor | |||
| 0.164 | 0.028 | 0.164 | Nav1.1 sodium channel blocker | |||
| 0.145 | 0.01 | 0.145 | Thioredoxin reductase inhibitor | |||
| 0.169 | 0.035 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.193 | 0.059 | 0.193 | Mcl-1 antagonist | |||
| 0.156 | 0.025 | 0.243 | Catalase inhibitor | 0.243 0.009 CID_131320 | CID_131320 | |
| 0.151 | 0.021 | 0.151 | DOPA decarboxylase inhibitor | |||
| 0.166 | 0.036 | 0.166 | Adenylate cyclase inhibitor | |||
| 0.155 | 0.027 | 0.155 | GABA C receptor antagonist | 0.13 0.043 CID_131320 | ||
| 0.137 | 0.012 | 0.137 | Leukotriene synthesis inhibitor | |||
| 0.18 | 0.056 | 0.437 | Protein-tyrosine phosphatase inhibitor | 0.437 0.007 CID_131320 | CID_131320 | |
| 0.138 | 0.017 | 0.138 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.2 | 0.08 | 0.2 | Psychostimulant | |||
| 0.14 | 0.023 | 0.14 | Anabolic | 0.138 0.025 CID_131320 | ||
| 0.153 | 0.037 | 0.153 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.223 | 0.108 | 0.223 | Transcription factor STAT inhibitor | |||
| 0.14 | 0.026 | 0.14 | GABA C receptor rho-1 antagonist | |||
| 0.116 | 0.006 | 0.116 | Aconitate hydratase inhibitor | |||
| 0.17 | 0.06 | 0.211 | Phospholipase A2 inhibitor | 0.211 0.037 CID_131320 | CID_131320 | |
| 0.148 | 0.039 | 0.207 | Aminopeptidase B inhibitor | 0.207 0.02 CID_131320 | CID_131320 | |
| 0.124 | 0.015 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.072 0.033 CID_131320 | ||
| 0.13 | 0.021 | 0.13 | Adrenaline agonist | |||
| 0.138 | 0.029 | 0.138 | Estrogen antagonist | |||
| 0.123 | 0.016 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.128 | 0.02 | 0.128 | Glutamate dehydrogenase inhibitor | 0.074 0.051 CID_131320 | ||
| 0.125 | 0.02 | 0.125 | Keratolytic | |||
| 0.15 | 0.047 | 0.15 | Heat shock protein 70 antagonist | |||
| 0.116 | 0.013 | 0.156 | Carbonic anhydrase VB inhibitor | 0.156 0.008 CID_131320 | CID_131320 | |
| 0.142 | 0.04 | 0.142 | DNA repair enzyme inhibitor | |||
| 0.117 | 0.015 | 0.117 | D-Ala-D-Ala ligase inhibitor | |||
| 0.128 | 0.027 | 0.137 | Carbonic anhydrase XIII inhibitor | 0.137 0.024 CID_131320 | CID_131320 | |
| 0.14 | 0.04 | 0.14 | Expectorant | |||
| 0.113 | 0.014 | 0.113 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.147 | 0.048 | 0.147 | Monophenol monooxygenase inhibitor | 0.114 0.066 CID_131320 | ||
| 0.157 | 0.059 | 0.367 | Hemostatic | 0.367 0.01 CID_131320 | CID_131320 | |
| 0.143 | 0.046 | 0.143 | Vanilloid 1 agonist | |||
| 0.121 | 0.025 | 0.121 | Ornithine decarboxylase inhibitor | |||
| 0.118 | 0.022 | 0.157 | Carbonic anhydrase V inhibitor | 0.157 0.013 CID_131320 | CID_131320 | |
| 0.116 | 0.02 | 0.116 | Estrogen receptor alpha antagonist | |||
| 0.139 | 0.044 | 0.139 | Microtubule formation inhibitor | |||
| 0.135 | 0.04 | 0.135 | Xanthine oxidase inhibitor | |||
| 0.114 | 0.02 | 0.114 | Interferon agonist | 0.081 0.051 CID_131320 | ||
| 0.193 | 0.1 | 0.193 | Hypolipemic | |||
| 0.127 | 0.034 | 0.127 | Uric acid excretion stimulant | |||
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR6) antagonist | |||
| 0.122 | 0.03 | 0.122 | Estrogen receptor beta antagonist | |||
| 0.143 | 0.051 | 0.143 | Cathepsin H inhibitor | |||
| 0.097 | 0.005 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.02 CID_131320 | ||
| 0.121 | 0.03 | 0.121 | Thioredoxin inhibitor | |||
| 0.169 | 0.078 | 0.169 | Tumour necrosis factor antagonist | |||
| 0.163 | 0.073 | 0.163 | Neurotensin receptor agonist | |||
| 0.113 | 0.023 | 0.113 | Glutamate decarboxylase inhibitor | |||
| 0.122 | 0.034 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.184 | 0.096 | 0.184 | Anticonvulsant | |||
| 0.103 | 0.015 | 0.103 | Purinergic P2X1 antagonist | 0.064 0.038 CID_131320 | ||
| 0.228 | 0.14 | 0.228 | Prostaglandin dehydrogenase inhibitor | |||
| 0.166 | 0.078 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.112 | 0.025 | 0.112 | Phosphodiesterase 3A inhibitor | |||
| 0.25 | 0.164 | 0.386 | 15-Lipoxygenase inhibitor | 0.386 0.08 CID_131320 | CID_131320 | |
| 0.105 | 0.019 | 0.105 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.104 | 0.018 | 0.104 | Argininosuccinate synthase inhibitor | |||
| 0.103 | 0.018 | 0.103 | Prostaglandin EP2 antagonist | |||
| 0.113 | 0.029 | 0.113 | Transcription factor NF kappa B stimulant | |||
| 0.091 | 0.008 | 0.131 | Alpha-mannosidase inhibitor | 0.131 0.004 CID_131320 | CID_131320 | |
| 0.088 | 0.004 | 0.088 | GABA uptake inhibitor | |||
| 0.093 | 0.01 | 0.093 | Sphingosine kinase 2 inhibitor | |||
| 0.093 | 0.011 | 0.093 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.105 | 0.023 | 0.11 | Carbonic anhydrase VA inhibitor | 0.11 0.021 CID_131320 | CID_131320 | |
| 0.124 | 0.042 | 0.124 | Beta glucuronidase inhibitor | |||
| 0.098 | 0.018 | 0.098 | Vanilloid 4 agonist | |||
| 0.092 | 0.012 | 0.092 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.054 0.036 CID_131320 | ||
| 0.109 | 0.03 | 0.113 | Cathepsin G inhibitor | 0.113 0.029 CID_131320 | CID_131320 | |
| 0.094 | 0.015 | 0.094 | Interferon inducer | 0.069 0.036 CID_131320 | ||
| 0.182 | 0.104 | 0.812 | Angiogenesis stimulant | 0.812 0.004 CID_131320 | CID_131320 | |
| 0.109 | 0.031 | 0.109 | CYP2A6 inhibitor | |||
| 0.103 | 0.026 | 0.103 | Aminopeptidase I inhibitor | |||
| 0.081 | 0.004 | 0.081 | Liver X receptor beta antagonist | |||
| 0.112 | 0.036 | 0.112 | Histamine N-methyltransferase inhibitor | |||
| 0.125 | 0.049 | 0.125 | Nav1.5 sodium channel blocker | |||
| 0.113 | 0.037 | 0.123 | Protein kinase C zeta inhibitor | 0.123 0.03 CID_131320 | CID_131320 | |
| 0.083 | 0.008 | 0.129 | Mannosidase inhibitor | 0.129 0.004 CID_131320 | CID_131320 | |
| 0.105 | 0.03 | 0.105 | Myeloperoxidase inhibitor | |||
| 0.1 | 0.025 | 0.1 | Estrogen-related receptor beta agonist | |||
| 0.079 | 0.004 | 0.079 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.191 | 0.117 | 0.191 | Tumour necrosis factor alpha release inhibitor | 0.191 0.117 CID_131320 | ||
| 0.081 | 0.007 | 0.081 | Liver X receptor alpha agonist | |||
| 0.103 | 0.029 | 0.103 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.122 | 0.048 | 0.122 | AMP-activated protein kinase stimulant | |||
| 0.147 | 0.073 | 0.147 | MAP kinase 3 inhibitor | |||
| 0.08 | 0.007 | 0.08 | Thymidylate synthase inhibitor | |||
| 0.091 | 0.018 | 0.091 | Androgen agonist | 0.063 0.037 CID_131320 | ||
| 0.085 | 0.012 | 0.085 | Topoisomerase II beta inhibitor | |||
| 0.077 | 0.005 | 0.077 | Cytokine production stimulant | |||
| 0.091 | 0.019 | 0.109 | Estrogen agonist | 0.109 0.015 CID_131320 | CID_131320 | |
| 0.129 | 0.057 | 0.15 | Cholesterol synthesis inhibitor | 0.15 0.045 CID_131320 | CID_131320 | |
| 0.086 | 0.014 | 0.086 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.074 | 0.003 | 0.074 | Ceramide glucosyltransferase inhibitor | 0.067 0.004 CID_131320 | ||
| 0.102 | 0.031 | 0.102 | mTOR complex 2 inhibitor | |||
| 0.103 | 0.032 | 0.103 | Somatostatin 1 agonist | |||
| 0.101 | 0.031 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.11 0.023 CID_131320 | CID_131320 | |
| 0.085 | 0.016 | 0.085 | Dihydroorotate dehydrogenase inhibitor | 0.047 0.041 CID_131320 | ||
| 0.073 | 0.004 | 0.077 | Guanylate cyclase inhibitor | 0.077 0.003 CID_131320 | CID_131320 | |
| 0.084 | 0.015 | 0.084 | Carbonic anhydrase XIV inhibitor | |||
| 0.1 | 0.032 | 0.135 | Glycine receptor antagonist | 0.135 0.012 CID_131320 | CID_131320 | |
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.087 | 0.021 | 0.087 | Xanthine dehydrogenase inhibitor | |||
| 0.103 | 0.037 | 0.103 | Bromodomain-containing protein 2 inhibitor | |||
| 0.081 | 0.016 | 0.081 | Sphingosine kinase inhibitor | 0.059 0.041 CID_131320 | ||
| 0.082 | 0.018 | 0.082 | MDM2 inhibitor | |||
| 0.069 | 0.004 | 0.069 | Free fatty acid receptor 1 antagonist | |||
| 0.073 | 0.009 | 0.073 | Factor III inhibitor | |||
| 0.156 | 0.092 | 0.156 | Catenin beta inhibitor | |||
| 0.139 | 0.076 | 0.139 | Pregnane X receptor agonist | 0.123 0.12 CID_131320 | ||
| 0.132 | 0.069 | 0.132 | Toll-Like receptor antagonist | |||
| 0.142 | 0.079 | 0.142 | MAP kinase kinase 4 inhibitor | |||
| 0.104 | 0.041 | 0.124 | Bile acid receptor antagonist | 0.124 0.017 CID_131320 | CID_131320 | |
| 0.128 | 0.066 | 0.128 | Nav1.3 sodium channel blocker | |||
| 0.074 | 0.012 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.041 CID_131320 | ||
| 0.08 | 0.019 | 0.08 | Phosphodiesterase 1C inhibitor | |||
| 0.108 | 0.048 | 0.108 | Electrolyte absorption antagonist | |||
| 0.074 | 0.014 | 0.074 | Beta 2 adrenoreceptor agonist | |||
| 0.07 | 0.011 | 0.07 | Immunoglobulin Fc receptor antagonist | |||
| 0.072 | 0.012 | 0.072 | Adenosine deaminase inhibitor | 0.068 0.015 CID_131320 | ||
| 0.07 | 0.011 | 0.07 | Sphingosine 1-phosphate receptor agonist | |||
| 0.084 | 0.025 | 0.084 | Protein kinase C beta inhibitor | |||
| 0.064 | 0.005 | 0.064 | Melatonin receptor 1A agonist | |||
| 0.063 | 0.005 | 0.063 | Angiotensin AT1 receptor antagonist | |||
| 0.103 | 0.046 | 0.122 | Phosphodiesterase 6D inhibitor | 0.122 0.023 CID_131320 | CID_131320 | |
| 0.091 | 0.034 | 0.091 | GABA aminotransferase inhibitor | |||
| 0.061 | 0.004 | 0.061 | Sodium/glucose cotransporter inhibitor | |||
| 0.089 | 0.033 | 0.089 | Prostaglandin-E synthase inhibitor | |||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | |||
| 0.084 | 0.028 | 0.122 | Phospholipase D inhibitor | 0.122 0.006 CID_131320 | CID_131320 | |
| 0.071 | 0.015 | 0.071 | CD45 antagonist | |||
| 0.087 | 0.031 | 0.087 | Glycine receptor agonist | |||
| 0.118 | 0.064 | 0.118 | Interleukin 1b antagonist | |||
| 0.061 | 0.007 | 0.061 | Liver X receptor antagonist | |||
| 0.062 | 0.008 | 0.062 | Liver X receptor beta agonist | |||
| 0.058 | 0.005 | 0.058 | Angiotensin II receptor antagonist | |||
| 0.074 | 0.021 | 0.074 | Calcium channel P-type blocker | |||
| 0.148 | 0.096 | 0.148 | Nitric oxide antagonist | |||
| 0.056 | 0.005 | 0.056 | Liver X receptor alpha antagonist | |||
| 0.085 | 0.033 | 0.085 | GABA B receptor agonist | |||
| 0.096 | 0.045 | 0.096 | ATPase (Vacuolar H+) inhibitor | |||
| 0.083 | 0.032 | 0.083 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.069 | 0.019 | 0.069 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.081 | 0.031 | 0.081 | Bcl2 antagonist | |||
| 0.126 | 0.077 | 0.126 | Sodium channel (voltage-gated) blocker | |||
| 0.069 | 0.02 | 0.069 | Leukotriene B4 antagonist | 0.052 0.04 CID_131320 | ||
| 0.08 | 0.032 | 0.08 | Leukotriene antagonist | |||
| 0.058 | 0.01 | 0.058 | Retinoic acid alpha receptor agonist | |||
| 0.063 | 0.014 | 0.063 | CC chemokine 4 receptor antagonist | |||
| 0.111 | 0.063 | 0.121 | Acetylcholine release stimulant | 0.121 0.046 CID_131320 | CID_131320 | |
| 0.058 | 0.01 | 0.058 | RNA-directed RNA polymerase inhibitor | |||
| 0.059 | 0.011 | 0.059 | Retinoid X alpha receptor agonist | |||
| 0.151 | 0.103 | 0.151 | DNA methyltransferase I inhibitor | |||
| 0.053 | 0.006 | 0.053 | CF transmembrane conductance regulator antagonist | |||
| 0.054 | 0.007 | 0.054 | Uridine phosphorylase inhibitor | |||
| 0.058 | 0.011 | 0.058 | Nerve growth factor antagonist | |||
| 0.102 | 0.056 | 0.102 | Glutamate (mGluR7) agonist | |||
| 0.051 | 0.005 | 0.051 | Estrogen-related receptor beta antagonist | |||
| 0.074 | 0.029 | 0.074 | Beta 3 adrenoreceptor antagonist | |||
| 0.115 | 0.07 | 0.115 | Anesthetic local | |||
| 0.075 | 0.03 | 0.075 | Aromatase inhibitor | |||
| 0.066 | 0.021 | 0.066 | DNA helicase inhibitor | |||
| 0.134 | 0.089 | 0.134 | Thiol protease inhibitor | |||
| 0.088 | 0.043 | 0.088 | Macrophage migration inhibitory factor inhibitor | |||
| 0.238 | 0.194 | 0.238 | Alpha-glucosidase inhibitor | |||
| 0.058 | 0.014 | 0.058 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.062 | 0.019 | 0.062 | Farnesyltransferase inhibitor | |||
| 0.058 | 0.014 | 0.058 | Thymidine kinase inhibitor | |||
| 0.132 | 0.089 | 0.132 | Cytidine deaminase inhibitor | |||
| 0.053 | 0.011 | 0.053 | Glutamate (mGluR3) antagonist | |||
| 0.061 | 0.019 | 0.061 | Squalene epoxidase inhibitor | |||
| 0.052 | 0.01 | 0.052 | Glutamate (mGluR8) agonist | |||
| 0.054 | 0.012 | 0.054 | Fumarate hydratase inhibitor | |||
| 0.055 | 0.013 | 0.055 | Glutamate (mGluR group II) antagonist | |||
| 0.051 | 0.01 | 0.051 | Glucagon receptor antagonist | |||
| 0.11 | 0.07 | 0.209 | Protein-tyrosine phosphatase 1B inhibitor | 0.209 0.027 CID_131320 | CID_131320 | |
| 0.054 | 0.013 | 0.054 | Sphingosine kinase 1 inhibitor | |||
| 0.053 | 0.013 | 0.07 | Phosphoglycerate kinase inhibitor | 0.07 0.01 CID_131320 | CID_131320 | |
| 0.055 | 0.016 | 0.055 | Retinoid X receptor agonist | |||
| 0.061 | 0.021 | 0.105 | Heparanase inhibitor | 0.105 0.004 CID_131320 | CID_131320 | |
| 0.068 | 0.028 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.077 | 0.038 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.063 | 0.024 | 0.063 | Leukotriene C antagonist | |||
| 0.049 | 0.01 | 0.049 | HCV NS5B polymerase inhibitor | |||
| 0.066 | 0.028 | 0.066 | Ornithine carbamoyltransferase inhibitor | |||
| 0.051 | 0.013 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.058 | 0.021 | 0.058 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.072 | 0.035 | 0.072 | Beta adrenoreceptor antagonist | |||
| 0.053 | 0.016 | 0.053 | Dopamine D5 agonist | |||
| 0.087 | 0.051 | 0.087 | Glutathione S-transferase inhibitor | |||
| 0.067 | 0.03 | 0.067 | Prolactin release inhibitor | |||
| 0.118 | 0.082 | 0.118 | Cyclooxygenase 1 inhibitor | |||
| 0.065 | 0.029 | 0.065 | Bruton tyrosine kinase inhibitor | |||
| 0.101 | 0.065 | 0.101 | Urease inhibitor | |||
| 0.067 | 0.032 | 0.067 | Cyclin D1 inhibitor | |||
| 0.073 | 0.037 | 0.073 | Exportin-1 inhibitor | |||
| 0.068 | 0.032 | 0.068 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.185 | 0.149 | 0.185 | Neuropeptide Y2 antagonist | |||
| 0.044 | 0.009 | 0.044 | Prostaglandin EP4 antagonist | |||
| 0.06 | 0.025 | 0.06 | Phosphorylase inhibitor | |||
| 0.054 | 0.02 | 0.054 | Dihydroorotase inhibitor | |||
| 0.07 | 0.036 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.069 0.038 CID_131320 | ||
| 0.15 | 0.117 | 0.15 | DNA methylase inhibitor | |||
| 0.037 | 0.004 | 0.037 | Complement factor 1s inhibitor | 0.027 0.012 CID_131320 | ||
| 0.06 | 0.028 | 0.06 | Thromboxane A2 antagonist | |||
| 0.109 | 0.076 | 0.109 | Proteasome inhibitor | |||
| 0.051 | 0.018 | 0.051 | Urate transporter 1 inhibitor | |||
| 0.049 | 0.017 | 0.049 | Estrogen receptor alpha agonist | |||
| 0.06 | 0.029 | 0.06 | Dihydroorotate oxidase inhibitor | |||
| 0.059 | 0.029 | 0.059 | Thromboxane synthase inhibitor | |||
| 0.107 | 0.076 | 0.107 | TRPA1 agonist | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | |||
| 0.151 | 0.121 | 0.151 | MAP kinase kinase 2 inhibitor | |||
| 0.051 | 0.021 | 0.051 | Geranyltranstransferase inhibitor | |||
| 0.1 | 0.07 | 0.1 | Mediator release inhibitor | |||
| 0.034 | 0.005 | 0.034 | G-protein-coupled receptor 120 agonist | |||
| 0.047 | 0.018 | 0.047 | Heme oxygenase inhibitor | |||
| 0.036 | 0.007 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CID_131320 | ||
| 0.173 | 0.144 | 0.173 | Calpain inhibitor | |||
| 0.049 | 0.02 | 0.06 | Dihydrofolate reductase inhibitor | 0.06 0.01 CID_131320 | CID_131320 | |
| 0.049 | 0.02 | 0.049 | Beta adrenoreceptor agonist | |||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | |||
| 0.161 | 0.133 | 0.161 | Free radical scavenger | |||
| 0.053 | 0.025 | 0.053 | Dopamine beta hydroxylase inhibitor | |||
| 0.042 | 0.014 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.128 | 0.1 | 0.128 | Heat shock protein 90 antagonist | |||
| 0.06 | 0.032 | 0.06 | Pregnane X receptor antagonist | |||
| 0.127 | 0.099 | 0.127 | Acetylcholine M1 receptor antagonist | |||
| 0.109 | 0.082 | 0.109 | MAO inhibitor | |||
| 0.034 | 0.008 | 0.034 | Geranylgeranyltransferase inhibitor | |||
| 0.134 | 0.107 | 0.134 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.036 | 0.01 | 0.036 | Prostaglandin EP2 agonist | |||
| 0.049 | 0.023 | 0.049 | Liver X receptor agonist | |||
| 0.038 | 0.013 | 0.038 | Glutamate (mGluR2) antagonist | |||
| 0.044 | 0.019 | 0.044 | Aggrecanase 1 inhibitor | |||
| 0.1 | 0.075 | 0.13 | Nav1.4 sodium channel blocker | 0.13 0.045 CID_131320 | CID_131320 | |
| 0.04 | 0.015 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.049 | 0.024 | 0.049 | AICAR transformylase inhibitor | |||
| 0.044 | 0.019 | 0.044 | Retinoid X receptor antagonist | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.049 | 0.025 | 0.049 | Phosphodiesterase 3B inhibitor | |||
| 0.108 | 0.084 | 0.108 | Transcription factor STAT6 inhibitor | |||
| 0.159 | 0.135 | 0.159 | Antiamyloidogenic | |||
| 0.031 | 0.007 | 0.031 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.097 | 0.073 | 0.097 | Falcipain 3 inhibitor | |||
| 0.037 | 0.013 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.03 | 0.006 | 0.03 | Free fatty acid receptor 1 agonist | |||
| 0.037 | 0.013 | 0.037 | Purinergic P2Y14 antagonist | |||
| 0.054 | 0.031 | 0.054 | Beta 2 adrenoreceptor antagonist | |||
| 0.062 | 0.039 | 0.062 | Phosphodiesterase 1B inhibitor | |||
| 0.039 | 0.016 | 0.039 | Melatonin agonist | |||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.037 | 0.015 | 0.037 | ATP citrate lysase inhibitor | |||
| 0.041 | 0.02 | 0.041 | Delayed rectifier potassium channel blocker | |||
| 0.113 | 0.092 | 0.113 | NADPH oxidase inhibitor | |||
| 0.146 | 0.124 | 0.146 | I kappa B kinase epsilon inhibitor | |||
| 0.042 | 0.021 | 0.042 | Diamine oxidase inhibitor | |||
| 0.105 | 0.084 | 0.105 | Caspase 3 inhibitor | |||
| 0.081 | 0.061 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.032 | 0.012 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.052 | 0.032 | 0.052 | Potassium channel (Inward rectifier) blocker | |||
| 0.029 | 0.009 | 0.029 | Geranylgeranyltransferase I inhibitor | |||
| 0.068 | 0.049 | 0.068 | Elastase 1 inhibitor | |||
| 0.024 | 0.004 | 0.024 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.051 | 0.031 | 0.051 | Antimetabolite | |||
| 0.038 | 0.019 | 0.038 | Sirtuin 2 inhibitor | |||
| 0.041 | 0.022 | 0.041 | Leukotriene C4 antagonist | |||
| 0.134 | 0.115 | 0.134 | LIM domain kinase 1 inhibitor | |||
| 0.057 | 0.038 | 0.057 | Beta 1 adrenoreceptor antagonist | |||
| 0.048 | 0.029 | 0.048 | Adenylate cyclase 1 inhibitor | |||
| 0.192 | 0.174 | 0.192 | Immunomodulator | |||
| 0.119 | 0.101 | 0.119 | Cyclooxygenase inhibitor | |||
| 0.098 | 0.08 | 0.098 | GABA receptor agonist | |||
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | |||
| 0.062 | 0.044 | 0.062 | I kappa B kinase 2 inhibitor | |||
| 0.037 | 0.02 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.03 | 0.013 | 0.03 | Hedgehog signaling activator | |||
| 0.026 | 0.009 | 0.026 | Imidazoline I1 receptor antagonist | |||
| 0.056 | 0.038 | 0.086 | Adenine nucleotide translocase inhibitor | 0.086 0.007 CID_131320 | CID_131320 | |
| 0.034 | 0.017 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.08 | 0.063 | 0.08 | Calcium antagonist | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.022 | 0.005 | 0.022 | Angiotensin AT1B receptor antagonist | |||
| 0.029 | 0.012 | 0.029 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.054 | 0.037 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.079 | 0.063 | 0.079 | Caspase 7 inhibitor | |||
| 0.081 | 0.065 | 0.081 | Androgen antagonist | |||
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.12 | 0.104 | 0.214 | Diuretic | 0.214 0.039 CID_131320 | CID_131320 | |
| 0.024 | 0.008 | 0.024 | Toll-Like receptor 8 agonist | |||
| 0.061 | 0.046 | 0.061 | Histone deacetylase SIRT3 inhibitor | |||
| 0.073 | 0.058 | 0.073 | Topoisomerase II alpha inhibitor | |||
| 0.022 | 0.007 | 0.022 | Adenosine A2a receptor agonist | |||
| 0.06 | 0.046 | 0.06 | NMDA receptor glycine site agonist | |||
| 0.039 | 0.025 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 CID_131320 | CID_131320 | |
| 0.06 | 0.045 | 0.06 | NMDA 2C receptor antagonist | 0.055 0.053 CID_131320 | ||
| 0.039 | 0.025 | 0.039 | TRPM8 blocker | |||
| 0.057 | 0.043 | 0.175 | HIV-1 integrase (Strand Transfer) inhibitor | 0.175 0.011 CID_131320 | CID_131320 | |
| 0.125 | 0.111 | 0.125 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.023 | 0.009 | 0.023 | Retinoic acid beta receptor agonist | |||
| 0.083 | 0.07 | 0.083 | Phosphodiesterase I inhibitor | |||
| 0.025 | 0.012 | 0.025 | Beta 1 adrenoreceptor agonist | |||
| 0.044 | 0.03 | 0.044 | Glutamate (mGluR group III) antagonist | |||
| 0.064 | 0.051 | 0.064 | Potassium channel (ATP-sensitive) blocker | |||
| 0.032 | 0.019 | 0.032 | Prostaglandin agonist | |||
| 0.063 | 0.051 | 0.063 | Neuronal nicotinic receptor antagonist | |||
| 0.025 | 0.012 | 0.025 | Adenosine kinase inhibitor | |||
| 0.06 | 0.047 | 0.109 | NMDA receptor agonist | 0.109 0.016 CID_131320 | CID_131320 | |
| 0.023 | 0.01 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.02 | 0.008 | 0.02 | Telomerase stimulant | |||
| 0.078 | 0.066 | 0.078 | GABA A receptor agonist | |||
| 0.02 | 0.008 | 0.02 | Adenosine A2 receptor agonist | |||
| 0.058 | 0.047 | 0.058 | Bcl-xL inhibitor | |||
| 0.028 | 0.017 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.135 | 0.124 | 0.312 | Platelet adhesion inhibitor | 0.312 0.03 CID_131320 | CID_131320 | |
| 0.025 | 0.015 | 0.048 | Glutamate (mGluR1) agonist | 0.048 0.005 CID_131320 | CID_131320 | |
| 0.186 | 0.175 | 0.186 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.024 | 0.014 | 0.024 | ICAM 1 antagonist | |||
| 0.024 | 0.013 | 0.13 | Glutamate (mGluR1a) agonist | 0.13 0.003 CID_131320 | CID_131320 | |
| 0.085 | 0.075 | 0.085 | ABCA1 expression enhancer | |||
| 0.021 | 0.011 | 0.023 | Follicle-stimulating hormone antagonist | 0.023 0.008 CID_131320 | CID_131320 | |
| 0.024 | 0.014 | 0.024 | Leukotriene B4 receptor 2 antagonist | |||
| 0.047 | 0.038 | 0.047 | Prostaglandin E2 antagonist | |||
| 0.035 | 0.026 | 0.035 | Nicotinic acid receptor agonist | |||
| 0.038 | 0.028 | 0.038 | Alpha 1d adrenoreceptor agonist | |||
| 0.02 | 0.011 | 0.02 | Antibiotic Anthracycline-like | |||
| 0.056 | 0.047 | 0.056 | Alpha 2 adrenoreceptor agonist | |||
| 0.041 | 0.033 | 0.041 | GABA B receptor antagonist | |||
| 0.027 | 0.019 | 0.14 | NMDA 2D receptor antagonist | 0.14 0.003 CID_131320 | CID_131320 | |
| 0.023 | 0.016 | 0.023 | Prostaglandin E2 agonist | |||
| 0.072 | 0.065 | 0.072 | Acetylcholine nicotinic antagonist | |||
| 0.105 | 0.098 | 0.105 | Cyclooxygenase 2 inhibitor | |||
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.113 | 0.106 | 0.113 | Activin receptor-like kinase 2 inhibitor | |||
| 0.081 | 0.074 | 0.081 | MAO B inhibitor | |||
| 0.018 | 0.012 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.019 | 0.013 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.025 | 0.019 | 0.025 | Thyroid hormone agonist | |||
| 0.031 | 0.025 | 0.031 | Melatonin 2 agonist | |||
| 0.067 | 0.061 | 0.067 | Acetylcholine M4 receptor antagonist | |||
| 0.041 | 0.035 | 0.041 | Glutamate (mGluR4) antagonist | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.03 | 0.025 | 0.03 | Cholesterol ester transfer protein antagonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | |||
| 0.035 | 0.03 | 0.035 | Integrin alpha2 antagonist | |||
| 0.05 | 0.046 | 0.05 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.026 | 0.021 | 0.026 | Leukotriene B4 receptor 1 antagonist | |||
| 0.028 | 0.024 | 0.028 | Estrogen receptor beta agonist | |||
| 0.044 | 0.04 | 0.044 | Aldosterone antagonist | |||
| 0.039 | 0.035 | 0.039 | Macrophage elastase inhibitor | |||
| 0.064 | 0.059 | 0.064 | HIV-1 integrase inhibitor | |||
| 0.046 | 0.042 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.084 | 0.08 | 0.084 | MAP kinase kinase 1 inhibitor | |||
| 0.051 | 0.047 | 0.051 | Epithelial sodium channel blocker | |||
| 0.027 | 0.024 | 0.027 | Purinergic P2Y15 antagonist | |||
| 0.032 | 0.029 | 0.032 | Purinergic P2X3 antagonist | |||
| 0.013 | 0.01 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.069 | 0.067 | 0.069 | Metalloproteinase-2 inhibitor | |||
| 0.054 | 0.052 | 0.054 | Acetylcholine M5 receptor antagonist | |||
| 0.039 | 0.037 | 0.039 | NMDA receptor subunit 3B antagonist | |||
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.047 | 0.045 | 0.05 | Carbonic anhydrase IX inhibitor | 0.05 0.043 CID_131320 | CID_131320 | |
| 0.042 | 0.04 | 0.042 | Potassium channel Kv1.3 blocker | |||
| 0.031 | 0.03 | 0.031 | Arginase inhibitor | |||
| 0.099 | 0.097 | 0.099 | Cholinergic antagonist | |||
| 0.058 | 0.057 | 0.058 | Matrix metalloproteinase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.055 | 0.054 | 0.143 | HIV-1 integrase (3'-Processing) inhibitor | 0.143 0.014 CID_131320 | CID_131320 | |
| 0.01 | 0.009 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.096 | 0.095 | 0.096 | Histone deacetylase class III inhibitor | |||
| 0.066 | 0.065 | 0.066 | Metalloproteinase-9 inhibitor | |||
| 0.021 | 0.02 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.014 | 0.014 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 CID_131320 | CID_131320 | |
| 0.049 | 0.061 | 0.364 | Selectin antagonist | 0.364 0.004 CID_131320 | CID_131320 | |
| 0.044 | 0.063 | 0.106 | Carbonic anhydrase inhibitor | 0.106 0.025 CID_131320 | CID_131320 | |
| 0.036 | 0.056 | 0.053 | Glutamate (mGluR5) agonist | 0.053 0.023 CID_131320 | CID_131320 | |
| 0.037 | 0.058 | 0.064 | Carbonic anhydrase I inhibitor | 0.064 0.032 CID_131320 | CID_131320 | |
| 0.033 | 0.056 | 0.05 | Glutamate (mGluR group I) agonist | 0.05 0.031 CID_131320 | CID_131320 | |
| 0.036 | 0.06 | 0.05 | Carbonic anhydrase II inhibitor | 0.05 0.044 CID_131320 | CID_131320 | |
| 0.113 | 0.138 | 0.651 | Dual specificity phosphatase 3 inhibitor | 0.651 0.004 CID_131320 | CID_131320 | |
| 0.065 | 0.09 | 0.116 | NMDA receptor antagonist | 0.116 0.037 CID_131320 | CID_131320 | |
| 0.097 | 0.122 | 0.148 | Alkaline phosphatase inhibitor | 0.148 0.061 CID_131320 | CID_131320 | |
| 0.058 | 0.085 | 0.336 | CDC25A inhibitor | 0.336 0.003 CID_131320 | CID_131320 | |
| 0.021 | 0.048 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.008 CID_131320 | CID_131320 | |
| 0.072 | 0.106 | 0.095 | Gastric antisecretory | 0.095 0.071 CID_131320 | CID_131320 | |
| 0.108 | 0.164 | 0.642 | Dual specificity phosphatase inhibitor | 0.642 0.004 CID_131320 | CID_131320 | |
| 0.035 | 0.101 | 0.08 | NMDA 2 receptor antagonist | 0.08 0.044 CID_131320 | CID_131320 | |
| 0.024 | 0.093 | 0.054 | Leukocyte elastase inhibitor | 0.054 0.021 CID_131320 | CID_131320 | |
| 0.032 | 0.103 | 0.268 | Factor IXa inhibitor | 0.268 0.003 CID_131320 | CID_131320 | |
| 0.077 | 0.162 | 0.189 | Cell adhesion inhibitor | 0.189 0.028 CID_131320 | CID_131320 | |
| 0.02 | 0.108 | 0.595 | Cholecystokinin B agonist | 0.595 0.002 CID_131320 | CID_131320 | |
| 0.018 | 0.107 | 0.062 | Purinergic P2Y2 antagonist | 0.062 0.007 CID_131320 | CID_131320 | |
| 0.017 | 0.117 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CID_131320 | CID_131320 | |
| 0.051 | 0.151 | 0.285 | Cell adhesion molecule inhibitor | 0.285 0.005 CID_131320 | CID_131320 | |
| 0.004 | 0.154 | 0.073 | Estrone sulfatase inhibitor | 0.073 0.005 CID_131320 | CID_131320 | |
| 0.01 | 0.16 | 0.074 | Factor Xa inhibitor | 0.074 0.019 CID_131320 | CID_131320 | |
| 0.005 | 0.207 | 0.354 | Cholecystokinin A agonist | 0.354 0.002 CID_131320 | CID_131320 | |
| 0.043 | 0.266 | 0.311 | Thrombolytic | 0.311 0.022 CID_131320 | CID_131320 | |
| 0.004 | 0.23 | 0.483 | Cholecystokinin agonist | 0.483 0.002 CID_131320 | CID_131320 | |
| 0.011 | 0.29 | 0.067 | Neuraminidase inhibitor | 0.067 0.036 CID_131320 | CID_131320 | |
| 0.016 | 0.301 | 0.109 | Neuraminidase (influenza) inhibitor | 0.109 0.014 CID_131320 | CID_131320 | |
| 0.004 | 0.338 | 0.186 | Cholecystokinin A antagonist | 0.186 0.005 CID_131320 | CID_131320 | |
| 0.004 | 0.348 | 0.087 | Cholecystokinin B antagonist | 0.087 0.005 CID_131320 | CID_131320 | |
| 0.004 | 0.364 | 0.108 | Cholecystokinin antagonist | 0.108 0.007 CID_131320 | CID_131320 | |
| 0.016 | 0.385 | 0.095 | Fibroblast growth factor 1 antagonist | 0.095 0.062 CID_131320 | CID_131320 | |
| 0.032 | 0.411 | 0.803 | Anticoagulant | 0.803 0.004 CID_131320 | CID_131320 | |
| 0.046 | 0.508 | 0.9 | Angiogenesis inhibitor | 0.9 0.004 CID_131320 | CID_131320 | |
| 0.005 | 0.478 | 0.24 | NMDA 2B receptor antagonist | 0.24 0.005 CID_131320 | CID_131320 | |
| 0.012 | 0.505 | 0.107 | Thrombin inhibitor | 0.107 0.022 CID_131320 | CID_131320 | |
| 0.008 | 0.519 | 0.103 | Elastase inhibitor | 0.103 0.009 CID_131320 | CID_131320 | |
| 0.012 | 0.704 | 0.129 | Multidrug resistance-associated protein 1 inhibitor | 0.129 0.039 CID_131320 | CID_131320 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |